The Journal of Organic Chemistry
Note
(E)-1,3-Dibenzyl-2-((4-nitrophenyl)triaz-2-en-1-ylidene)-2,3-
dihydro-1H-benzo[d]imidazole (6f). Red crystals (0.0.23 g, 77%),
mp 190−191 °C; 1H NMR (CDCl3) δ 7.99 (d, J = 8.4 Hz, 2H), 7.39−
7.29 (m, 10H), 7.20−7.15 (m, 6H), 5.65 (s, 4H); 13C NMR (CDCl3)
δ 156.1, 154.9, 145.5, 135.5, 131.4, 129.0, 128.0, 126.7, 124.5, 123.7,
121.7, 109.9, 48.4. Anal. Calcd For C27H22N6O2: C, 70.12; H, 4.76; N,
18.17. Found: C, 70.26; H, 4.87; N, 18.19.
mmol) in CH3CN (3 mL) and stirred under reflux. After 5 h, the
reaction mixture was concentrated under reduced pressure to afford 10
as red crystals (0.13g, >99%), mp 223 °C, dec; 1H NMR (DMSO-d6)
δ 8.14 (d, J = 9.3 Hz, 1H), 8.13 (d, J = 9.3 Hz, 1H), 8.03−7.94 (m,
2H), 7.68−7.59 (m, 2H), 7.48−7.30 (m, 12H), 5.92 (s, 4H), 3.99 (s,
3H); 13C NMR (DMSO-d6) δ 148.8, 146.7, 145.5, 134.8, 130.5, 128.8,
127.9, 126.8, 126.5, 124.6, 120.0, 112.9, 48.5, 36.5.
N-((E)-1-Benzyl-5-((E)-(4-nitrophenyl)triaz-2-en-1-ylidene)-
1H-1,2,4-triazol-4(5H)-yl)-4-methylbenzenesulfonamide (11a).
HCl (1 N) was added dropwise to the solution of 9a (0.10 g, 0.19
mmol) in MeOH (10 mL) until the formation of a yellow precipitate
stopped. The resulting precipitate was collected by filtration, washed
with water (10 mL), and dried to obtain pure 11a as yellow crystals
(0.079 g, 85%), mp 173 °C, dec; 1H NMR (DMSO-d6) δ 8.11 (s, 1H),
8.03 (d, J = 8.1 Hz, 2H), 7.46 (d, J = 7.8 Hz, 2H), 7.37−7.28 (m, 3H),
7.23 (d, J = 7.8 Hz, 2H), 7.07−6.99 (m, 4H), 5.35 (s, 2H), 2.16 (s,
3H); 13C NMR (DMSO-d6) δ 157.9, 153.9, 143.4, 142.7, 141.7, 139.7,
136.7, 128.6, 128.5, 127.5, 126.8, 126.5, 124.5, 120.7, 53.5, 20.9. Anal.
Calcd For C22H20N8O4S: C, 53.65; H, 4.09; N, 22.75. Found: C,
53.36; H, 3.80; N, 22.64.
(E)-1-Butyl-3-methyl-2-((E)-(4-nitrophenyl)triaz-2-en-1-yli-
dene)-2,3-dihydro-1H-benzo[d]imidazole (6g). Red crystals (0.19
1
g, 84%), mp 158−161 °C; H NMR (CDCl3) δ 8.24 (d, J = 12.0 Hz,
2H), 7.67 (d, J = 9.0 Hz, 2H), 7.38−7.28 (m, 4H), 4.36 (t, J = 7.5 Hz,
2H), 3.92 (s, 3H), 1.97−1.82 (m, 2H), 1.51−1.37 (m, 2H), 0.98 (t, J =
6.0 Hz, 3H); 13C NMR (CDCl3) δ 155.9, 153.6, 145.4, 131.6, 131.1,
124.8, 123.5, 123.5, 121.5, 109.5, 109.3, 44.8, 32.0, 30.9, 20.1, 13.9;
HRMS (+ESI-TOF) m/z for C18H21N6O2 [M + H]+ calcd 353.1721,
found 353.1731.
(E)-1-Butyl-3-methyl-2-((E)-(4-nitrophenyl)triaz-2-en-1-yli-
dene)-2,3-dihydro-1H-imidazole (6h). Red crystals (0.16 g, 83%),
1
mp 144−145 °C; H NMR (CDCl3) δ 8.20 (d, J = 9.0 Hz, 2H), 7.54
(d, J = 9.0 Hz, 2H), 6.67−6.56 (m, 2H), 4.12 (t, J = 7.5 Hz, 2H), 3.78
(s, 3H), 1.84−1.77 (m, 2H), 1.46−1.31 (m, 2H), 0.95 (t, J = 6.0 Hz,
3H); 13C NMR (CDCl3) δ 157.7, 125.6, 124.8, 120.6, 119.3, 117.6,
116.2, 47.8, 36.3, 31.7, 19.8, 13.7; HRMS (+ESI-TOF) m/z for
C14H19N6O2 [M + H]+ calcd 303.1564, found 303.1573.
General Method for the Preparation of 11b,c. A mixture of 9a
(0.1 g, 0.19 mmol) and alkyl halide (0.19 mmol, 1.9 mmol in the case
of methyl iodide) in acetonitrile (3 mL) was stirred under reflux. After
5 h, the precipitate was removed by filtration, and the filtrate was
concentrated under reduced pressure. The residue was recrystallized
from MeOH to obtain pure 11b,c.
General Method for the Preparation of Push-Pull Triazene
Salts 9a−d. Potassium tert-butoxide (0.063 g, 0.63 mmol) was added
to a mixture of 1-azido-4-nitrobenzene 5 (0.10 g, 0.63 mmol) and the
corresponding 1,2,4-triazolium N-imide 7a−d (0.63 mmol) in dry
THF (10 mL) at −78 °C. After 10 min, the reaction mixture was
warmed to room temperature and stirred. After 24 h the precipitate
was collected by filtration, washed with THF (5 mL), and dried to
obtain pure triazene salt 9a−d.
Potassium ((E)-1-Benzyl-5-((E)-(4-nitrophenyl)triaz-2-en-1-
ylidene)-1H-1,2,4-triazol-4(5H)-yl)(tosyl)amide (9a). Yellow-or-
ange crystals (0.29 g, 86%), mp 216−217 °C; 1H NMR (DMSO-d6) δ
8.11 (s, 1H), 8.03 (d, J = 8.7 Hz, 2H), 7.46 (d, J = 7.5 Hz, 2H), 7.36−
7.29 (m, 3H), 7.23 (d, J = 8.7 Hz, 2H), 7.10−6.97 (m, 4H), 5.35 (s,
2H), 2.16 (s, 3H); 13C NMR (DMSO-d6) δ 157.7, 153.7, 143.2, 142.5,
141.5, 139.6, 136.5, 128.4, 128.3, 127.4, 126.7, 126.3, 124.4, 120.5,
53.3, 20.7; HRMS (-ESI-TOF) m/z for C22H19N8O4S [M − K]− calcd
491.1255, found 491.1267.
Potassium ((E)-1-Butyl-5-((E)-(4-nitrophenyl)triaz-2-en-1-yli-
dene)-1H-1,2,4-triazol-4(5H)-yl)(tosyl)amide (9b). Orange crys-
tals (0.28 g, 94%), mp 215−216 °C; 1H NMR (DMSO-d6) δ 8.16 (d, J
= 9.0 Hz, 2H), 8.00 (s, 1H), 7.50−7.39 (m, 4H), 7.01 (d, J = 8.1 Hz,
2H), 4.08 (t, J = 7.1 Hz, 2H), 2.17 (s, 3H), 1.67−1.60 (m, 2H), 1.28−
1.14 (m, 2H), 0.84 (t, J = 7.4 Hz, 3H); 13C NMR (DMSO-d6) δ 158.4,
153.0, 143.0, 142.1, 142.0, 139.2, 128.2, 126.5, 124.5, 120.3, 49.6, 30.4,
20.7, 18.8, 13.4; HRMS (-ESI-TOF) m/z for C19H21N8O4S [M − K]−
calcd 457.1412, found 457.1430.
Potassium ((E)-1-Methyl-5-((E)-(4-nitrophenyl)triaz-2-en-1-
ylidene)-1H-1,2,4-triazol-4(5H)-yl)(tosyl)amide (9c). Yellow-or-
ange crystals (0.23 g, 79%), mp 202−203 °C; 1H NMR (DMSO-d6) δ
8.15 (d, J = 9.0 Hz, 2H), 7.94 (s, 1H), 7.49 (d, J = 8.1 Hz, 2H), 7.48
(d, J = 9.0 Hz, 2H), 7.05 (d, J = 7.8 Hz, 2H), 3.76 (s, 3H), 2.19 (s,
3H); 13C NMR (DMSO-d6) δ 158.3, 153.6, 143.1, 142.4, 141.8, 139.3,
128.3, 126.6, 124.7, 120.5, 39.0, 20.8; HRMS (-ESI-TOF) m/z for
C16H15N8O4S [M − K]− calcd 415.0942, found 415.0954.
N-((E)-1-Benzyl-5-((E)-(4-nitrophenyl)triaz-2-en-1-ylidene)-
1H-1,2,4-triazol-4(5H)-yl)-N,4-dimethylbenzenesulfonamide
1
(11b). Orange crystals (0.088 g, 92%), mp 174−175 °C; H NMR
(DMSO-d6) δ 8.82 (s, 1H), 8.11 (d, J = 8.1 Hz, 2H), 7.66 (d, J = 7.5
Hz, 2H), 7.45−7.33 (m, 3H), 7.28 (t, J = 7.7 Hz, 4H), 7.19 (d, J = 8.0
Hz, 2H), 5.40 (s, 2H), 3.47 (s, 3H), 2.22 (s, 3H); 13C NMR (DMSO-
d6) δ 155.7, 152.4, 145.1, 144.9, 140.4, 135.7, 132.4, 129.9, 128.5,
128.1, 127.6, 126.5, 124.4, 121.4, 53.5, 38.0, 21.0; HRMS (+ESI-TOF)
m/z for C23H23N8O4S [M + H]+ calcd 507.1557, found 507.1553.
N-Benzyl-N-((E)-1-benzyl-5-((E)-(4-nitrophenyl)triaz-2-en-1-
ylidene)-1H-1,2,4-triazol-4(5H)-yl)-4-methylbenzenesulfon-
amide (11c). Red crystals (0.097 g, 88%), mp 172−173 °C; 1H NMR
(DMSO-d6) δ 8.64 (s, 1H), 8.14 (d, J = 8.1 Hz, 2H), 7.80 (d, J = 7.3
Hz, 2H), 7.37−7.26 (m, 12H), 6.91 (d, J = 7.6 Hz, 2H), 5.41 (d, J =
16.8 Hz, 1H), 5.32 (d, J = 16.2 Hz, 1H), 5.04 (d, J = 13.8 Hz, 1H),
5.00 (d, J = 13.8 Hz, 1H), 2.26 (s, 3H).; 13C NMR (DMSO-d6) δ
155.6, 152.4, 145.3, 145.1, 140.8, 135.6, 132.9, 130.0, 129.0, 128.6,
128.5, 128.3, 127.5, 126.0, 124.4, 121.5, 53.8, 53.3, 21.0; HRMS
(+APCI-TOF) m/z for C29H27N8O4S [M + H]+ calcd 583.1870,
found 583.1861.
General Method for the Preparation of 12a,b. A mixture of 7a
(0.5 g, 1.5 mmol) and alkyl halide (1.5 mmol, 15.0 mmol in the case of
methyl iodide) in acetonitrile (15 mL) was stirred under reflux. After 5
h, the reaction mixture was concentrated under reduced pressure to
afford pure 12a,b.
1-Benzyl-4-(N,4-dimethylphenylsulfonamido)-1H-1,2,4-tria-
zol-4-ium Iodide (12a). White crystals (0.71 g, >99%), mp 168−170
1
°C; H NMR (DMSO-d6) δ 10.89 (s, 1H), 9.61 (s, 1H), 7.69 (d, J =
8.1 Hz, 2H), 7.57 (d, J = 8.1 Hz, 2H), 7.51−7.41 (m, 5H), 5.66 (s,
2H), 3.43 (s, 3H), 2.50 (s, 3H); 13C NMR (DMSO-d6) δ 147.2, 143.7,
143.3, 132.2, 130.9, 129.2, 129.0, 128.9, 127.0, 55.9, 39.2, 21.4. Anal.
Calcd For C17H19IN4O2S: C, 43.41; H, 4.07; N, 11.91. Found: C,
43.39; H, 3.78; N, 11.93.
1-Benzyl-4-(N-benzyl-4-methylphenylsulfonamido)-1H-
1,2,4-triazol-4-ium Bromide (12b). White crystals (0.76 g, >99%),
mp 137−139 °C; 1H NMR (DMSO-d6) δ 11.21 (s, 1H), 9.69 (s, 1H),
7.85 (d, J = 8.1 Hz, 2H), 7.60 (d, J = 8.1 Hz, 2H), 7.45−7.37 (m, 3H),
7.36−7.27 (m, 5H), 7.25−7.13 (m, 2H), 5.64 (s, 2H), 4.98 (s, 2H),
2.50 (s, 3H); 13C NMR (DMSO-d6) δ 147.2, 144.9, 143.8, 132.3,
131.6, 131.0, 129.1, 128.9, 128.9, 128.6, 128.4, 55.9, 55.2, 21.4. Anal.
Calcd For C23H23BrN4O2S: C, 55.31; H, 4.64; N, 11.22. Found: C,
55.40; H, 4.44; N, 11.28.
Potassium ((E)-1-Butyl-5-((E)-(4-nitrophenyl)triaz-2-en-1-yli-
dene)-1H-1,2,4-triazol-4(5H)-yl)((4-nitrophenyl)sulfonyl)amide
(9d). Orange crystals (0.32 g, 95%), mp 245−246 °C; 1H NMR
(DMSO-d6) δ 8.18 (s, 1H), 8.12 (d, J = 9.3 Hz, 2H), 8.00 (d, J = 8.7
Hz, 2H), 7.68 (d, J = 8.7 Hz, 2H), 7.32 (d, J = 9.3 Hz, 2H), 4.05 (t, J =
7.1 Hz, 2H), 1.70−1.58 (m, 2H), 1.31−1.12 (m, 2H), 0.84 (t, J = 7.4
Hz, 3H); 13C NMR (DMSO-d6) δ 158.0, 153.0, 151.2, 147.5, 143.2,
142.5, 127.8, 124.6, 123.1, 120.2, 49.7, 30.5, 19.0, 13.5; HRMS (-ESI-
TOF) m/z for C18H18N9O6S [M − K]− calcd 488.1106, found
488.1125.
(E)-3-(1,3-Dibenzyl-1H-benzo[d]imidazol-2(3H)-ylidene)-1-
methyl-1-(4-nitrophenyl)triaz-1-en-1-ium Iodide (10). Methyl
iodide (0.15g, 1.1 mmol) was added to a solution of 6f (0.10 g, 0.22
E
dx.doi.org/10.1021/jo302697q | J. Org. Chem. XXXX, XXX, XXX−XXX